NVision Imaging

NVision has developed a quantum-based platform which polarizes natural metabolites, enabling these safe molecules to be used as an agent for imaging tumor metabolism via standard MRI. This safe imaging technology will provide clinicians worldwide unprecedented early insights into treatment efficacy, allowing non-responders to be moved onto another line of therapy more quickly. The company is based in Ulm, Germany, and active throughout the US and Europe.
Revolutionizing medical imaging

Get to know NVision Imaging

  • Headquartered in: Ulm, Germany

  • Founded in: 2009

  • Sector: MedTech, Diagnostics

  • Investor: Private Investor Network, Industrial Tech Fund

Press enter or esc to cancel